News

"Each wound contains its own beauty..."

Data presented at ACNP meeting demonstrated safety, tolerability, and efficacy for SPN-820 for MDD.

Negative symptoms pose significant challenges for individuals with schizophrenia and their caregivers.

As the Terminally Ill Adults Bill moves through parliament, government representatives and doctors alike consider the effects legalization may have on patients of psychiatrists.

A poster at the ACNP Annual Meeting utilized a novel risk-informed case-control design to improve biomarker differentiation for ADHD.

Machine learning may help science better understand cognitive impairment in schizophrenia and improve prevention and patient care.

Do lifestyle interventions really work in Alzheimer disease and what are the underlying mechanisms? Learn more in this ACNP 2024 Annual Meeting session!

How can we prevent heat-related illness in patients with psychiatric disorders, who are more vulnerable to heat?

Thomas R. Kosten, MD, shares thoughts on the latest schizophrenia genetic model research presented at the meeting.

Check out 2 new psychopharmacology innovations!

Psychiatry: one of the most dynamic and rapidly evolving specialties in medicine.

New research links reduced synaptic density,early psychosis, and cannabis use, offering insights into negative symptoms and potential interventions.

Stephanie Gorka, PhD, shared findings at the ACNP Annual Meeting on orexin receptor agonists addressing AUDs.

In highlighting recent advances and fostering collaboration and networking, the ACNP Annual Meeting helps usher in 2025 with hope and positivity.

Thomas R. Kosten, MD, shares insights on the ACNP meeting along with his excitement for potential new treatments.

The presentation of catatonia can vary, making its management challenging, particularly in resource-limited settings in South Africa.

Let's look back on a year marked by advancements and ongoing challenges in psychiatry.

While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!

Psychiatric reflections on this weekend's news.

NIH directors discuss initiatives, advances, and more at the annual meeting.

Previewing the 63rd ACNP Annual Meeting, which is set to highlight the latest research in psychiatry.

Is the sobering news a wake-up call for managed care?

Festina lente—hurry up and slow down!

"Who would be a turtle who could help it?"

As a clinician, do you serve or empower your patients?

A recent New York Times “hard hitting expose” accused Acadia Healthcare of hospitalizing psychiatric patients inappropriately. What does this expose about psychiatric hospitalization?

Athletes are an underserved population in mental health care.

Gratitude: needed now more than ever.

Medical student Liz Irvin discusses how storytelling is integral to her ability to stay sensitive when it comes to medicine and education, and shares a poem about an experience she had caring for others before starting medical school.

Post-hoc analysis of the ELEKT-D trial of ketamine and ECT for patients with treatment-resistant depression distinguishes between responders to the respective interventions.